Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ārepa is a New Zealand-based brain health company that develops scientifically validated brain food designed to support cognitive function and mental clarity. The company's product line includes beverages, powders, and capsules formulated with unique natural ingredients such as Neuroberry blackcurrants, Enzogenol pine bark extract, and L-theanine. Ārepa distinguishes itself in the nutraceutical market by investing in clinical research and peer-reviewed studies to substantiate its claims regarding mental performance and stress reduction. Their mission is to delay the onset of neurological decline through accessible, plant-based nutrition. The company collaborates extensively with academic institutions to conduct human clinical trials on its finished formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ārepa.